Innovation of a novel anti-hypertensive therapy due to the inhibitionof aldosterone synthase (CYP11B2) gene expression

点击翻译按钮获取中文摘要

In the present study, we elucidated that both PPARγ and RXR agonists suppressed aldosterone synthase (CYP11B2) expression at the gene transcription level, while the supernatant of adipocytes induced CYP11B2 transcription activation. Additionally, we generated a stable H295R cell line expressing CYP11B2 promoter/luciferase chimeric reporter construct. Based on these observations, we are going to develop novel anti-hypertensive drugs.